Benford Mafuvadze, Ph.D.
Affiliations: | 2012 | Biomedical Sciences | University of Missouri - Columbia, Columbia, MO, United States |
Area:
Oncology, Endocrinology Biology, Molecular BiologyGoogle:
"Benford Mafuvadze"Parents
Sign in to add mentor| Salman M. Hyder | grad student | 2012 | University of Missouri - Columbia | |
| (Apigenin: Chemopreventive and chemotherapeutic potential for progestin-dependent breast cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Liang Y, Mafuvadze B, Besch-Williford C, et al. (2018) A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts. Breast Cancer (Dove Medical Press). 10: 53-67 |
| Goyette S, Liang Y, Mafuvadze B, et al. (2017) Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitro. Breast Cancer (Dove Medical Press). 9: 347-357 |
| Liang Y, Mafuvadze B, Aebi JD, et al. (2016) Cholesterol biosynthesis inhibitor RO 48-8071 suppresses growth of hormone-dependent and castration-resistant prostate cancer cells. Oncotargets and Therapy. 9: 3223-32 |
| Cook MT, Mafuvadze B, Besch-Williford C, et al. (2016) Luteolin suppresses development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats. Oncology Reports. 35: 825-32 |
| Goyette S, Mafuvadze B, Cook MT, et al. (2016) Abstract 1807: Progestin enrichment of the cancer stem cell-like pool provides novel therapeutic targets for hormone-dependent human breast cancer Cancer Research. 76: 1807-1807 |
| Cook MT, Liang Y, Besch-Williford C, et al. (2015) Luteolin inhibits progestin-dependent angiogenesis, stem cell-like characteristics, and growth of human breast cancer xenografts. Springerplus. 4: 444 |
| Liang Y, Mafuvadze B, Zou X, et al. (2015) Abstract 5422: Inhibition of oxidosqualene cyclase blocks proliferation and survival of prostate cancer cells Cancer Research. 75: 5422-5422 |
| Goyette S, Mafuvadze B, Cook MT, et al. (2015) Abstract 1867: Enrichment of CD44highstem-cell-like cells as a possible mechanism of progestin-dependent progression of human breast cancer Cancer Research. 75: 1867-1867 |
| Mafuvadze B, Liang Y, Hyder SM. (2014) Cholesterol synthesis inhibitor RO 48-8071 suppresses transcriptional activity of human estrogen and androgen receptor. Oncology Reports. 32: 1727-33 |
| Liang Y, Besch-Williford C, Aebi JD, et al. (2014) Cholesterol biosynthesis inhibitors as potent novel anti-cancer agents: suppression of hormone-dependent breast cancer by the oxidosqualene cyclase inhibitor RO 48-8071. Breast Cancer Research and Treatment. 146: 51-62 |